ReviewBreast (Edinburgh, Scotland)2021

Targeting ADCC: A different approach to HER2 breast cancer in the immunotherapy era.

Pablo Mandó et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.